Effects of levamisole hydrochloride on cellular immune response and flock performance of commercial broilers

Abstract

Levamisole hydrochloride (Lev.HCl) has been acclaimed to boost immune response particularly in immunocompromised state. Its routine use as an immunomodulator in poultry production is yet to be well embraced, thus its effects of on cellular immunity and flock performance of commercial broilers were evaluated.One hundred and fifty Anak broiler chicks were separated into two groups of 75 each. Broilers in group 1 were sensitized with 150µg of Staphylococcus aureus antigen each at 4 and 5 weeks, while those in group 2 were not sensitized. Each group was further divided into subgroups A, B, and C. Levamisole hydrochloride (40 mg/kg) was administered orally to 1A and 2A at 45 and 46 days of age and to 1B and 2B at 47 and 48 days of age, while 1C and 2C were not treated. At 47 days of age, 12 broilers from all subgroups were challenged with 75µg of S. aureus antigen each at the right wattle. Wattle thickness was measured till 72 hours post challenge (pc) and delayed wattle reaction (DWR) was determined. Tissues were harvested at 72 hours pc for histopathology. Morbidity, mortality and live weights at 8 weeks of age were recorded. DWR peaked at 4 hours pc in 1A (2.22 ± 0.21 mm) and 1B (2.96 ± 0.21 mm) and 24 hours pc in 1C (3.39 ± 0.34 mm), the difference being significant (p<0.05). Inflammatory lesions were observed in wattles of sensitized subgroups and were more severe in 1C. Mortality rates were 4.17% and 29.17% in 1A and 1C respectively. Mean live weights in A and B i.e. 1.57± 0.06 kg and 1.56 ± 0.06 kg respectively, were significantly higher (p<0.0) than 1.43 ± 0.08 kg in C. Levamisole enhanced DTH via an early response, improved broiler liveability, and its anti-inflammatory property was confirmed.

Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens

“…Besides the agonists of PRRs, some chemical compounds also possess immuno-stimulatory capabilities. The levamisole, an imidazole–thiazole group derivate which is an anthelminthic commonly used in veterinary and human medicine, is able to enhance both humoral and cellular immune responses in animal (Oladele et al, 2012). …”

COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management

“…LVM increases lymphocytes and boosts the immunity power of the body ( Ludvigsson, 2020 ). Besides, LVM can easily bind with Papaine Like Protease (PL-pro) of the virus which may decrease the severity of COVID-19 ( Oladele et al, 2012 ). This drug can also reduce the expression of TNF α and IL-6, which are responsible for COVID-19 pathogenesis.…”

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens

“…The MDP is recognized by NOD-like receptors (NOD)-2 ( Sonoda et al, 2000 ). Levamisole is an antiparasitic agent and is also capable of immune enhancement ( Oladele et al, 2012 ).…”